AcrySof® IQ PanOptix® Toric Trifocal IOL TFNT40 (REF TFNT40U185)Recalls & reported problems
Alcon Laboratories, Inc. · AcrySof® IQ PanOptix® Toric Trifocal intraocular lenses (IOLs) are ultraviolet absorbing and blue light filtering foldable multifocal IOLs · Class 3 · Implant
All models of AcrySof IQ PanOptix Toric Trifocal IOL (165)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00380652416023), received between Aug 16, 2021 and Apr 9, 2024 — classified as 3 injuries.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem3
Patient problems
- Halo3
- Visual Disturbances2
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
- Blurred Vision1
- Dry Eye(s)1
- Eye Pain1
- Visual Impairment1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryApr 9, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A NON-HEALTHCARE PROFESSIONAL REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT HAD HARD TIME DRIVING AT NIGHT DUE TO GLARE AND HALOS. THE IOL WAS PLANNED EXCHANGED FOR UNSPECIFIED ADVANCED TECHNOLOGY INTRAOCULAR LENSES (ATIOL). CLINICAL REASON FOR PLANNED EXPLANT WAS MENTIONED AS DESIGN OF IOL WITH DIFFRACTIVE RINGS CANNOT TOLERATE BY PATIENT. ADDITIONAL INFORMATION HAS BEEN RECEIVED STATING THAT THE PATIENT WENT IN FOR THE PLANNED EXPLANT BUT DURING THE OPERATION SURGEON HAD TO ABORT THE PROCEDURE DUE TO COMPLICATIONS.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Halo; Visual Disturbances
MAUDE report 19070670 ↗InjuryDec 28, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A CONSUMER REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE HE HAD TROUBLE WITH NIGHT DRIVING DUE TO THE RINGS, GLARE, AND HALOS HE SEES AROUND ALL LIGHT SOURCES. HE NOTICED ISSUE SINCE SURGERY. LAST VISIT TO SURGEON AND WAS TOLD I WOULD SUBSIDE OVER THE NEXT SEVERAL MONTHS. THE PATIENT HAS NOT NOTICED ANY IMPROVEMENT. THERE ARE TWO MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS PATIENT. THIS REPORT IS ASSOCIATED WITH THE RIGHT EYE.
Patient problems: Halo; Visual Disturbances
MAUDE report 16059171 ↗InjuryAug 16, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A CONSUMER REPORTED SORE EYES AND BLURRED VISION FOLLOWING INTRAOCULAR LENS (IOL) IMPLANTATION. SHE NOTED THAT THE RIGHT EYE WAS WORSE THAN THE LEFT EYE. IT WAS AS IF LOOKING THROUGH WATER, HAD DIFFICULTY-OPENING EYES AT NIGHT, HALO¿S AROUND HEADLIGHTS, SPIDER WEBS AROUND TRAFFIC LIGHTS AT NIGHT, FLORESCENT LIGHTING WAS A BLUR, WEEPING AND DRY EYES. THE SURGEON INDICATED THAT THE DRY EYES COULD BE THE CAUSE OF THE BLURRED VISION AND SORENESS, WHICH WAS PRESENT PRIOR TO THE IMPLANT PROCEDURE. ADDITIONAL INFORMATION RECEIVED FROM THE CONSUMER INDICATED THAT THE LENSES WERE EXPLANTED FOUR MONTHS FOLLOWING THE INITIAL IMPLANT PROCEDURE AND THE SYMPTOMS SUBSIDED. THERE ARE TWO MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS PATIENT. THIS REPORT IS FOR RIGHT EYE.
Patient problems: Blurred Vision; Dry Eye(s); Eye Pain; Halo; Visual Impairment
MAUDE report 12328530 ↗
Other Lens, multifocal intraocular devices
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular144 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular1 recall66 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular113 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular112 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular110 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular107 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular104 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular93 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page